These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 120893)

  • 1. [The biological fate of 4-butyl-4-(beta-carboxypropionyloxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione(suxibuzone), antiinflammatory drug. I. Plasma levels and urinary excretion after oral administration of suxibuzone (author's transl)].
    Shindo T; Yasuda Y; Taira K; Mitani N; Kanda A; Akazawa A
    Yakugaku Zasshi; 1979 Dec; 99(12):1186-200. PubMed ID: 120893
    [No Abstract]   [Full Text] [Related]  

  • 2. [The biological fate of 4-butyl-4-(beta-carboxypropionyloxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione (suxibuzone), antiinflammatory drug. II. The biological fate of suxibuzone (SB) after daily oral administration (author's transl)].
    Taira K; Yasuda Y; Shindo T; Mitani N; Akazawa A
    Yakugaku Zasshi; 1980 Mar; 100(3):272-9. PubMed ID: 7381687
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the absorption, excretion, and metabolism of suxibuzone and phenylbutazone in humans.
    Yasuda Y; Shindo T; Mitani N; Ishida N; Oono F; Kageyama T
    J Pharm Sci; 1982 May; 71(5):565-72. PubMed ID: 7097505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The disposition of suxibuzone in the horse.
    Delbeke FT; Vynckier L; Debackere M
    J Vet Pharmacol Ther; 1993 Sep; 16(3):283-90. PubMed ID: 8230399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 1. Serum levels and urinary excretion in rats, rabbits and dogs.
    Coppi G; Bonardi G; Perego R
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:234-6. PubMed ID: 5067199
    [No Abstract]   [Full Text] [Related]  

  • 6. Absorption and excretion of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in man and dog.
    Dean HG; Donovan B; Murray-Leslie C; Rylett P
    Arzneimittelforschung; 1976; 26(9):1700-4. PubMed ID: 1036704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The distribution and excretion of 14C- and 3H-labelled 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in the rat.
    Dean HG; Donovan B; Rylett P
    Arzneimittelforschung; 1976; 26(8):1574-81. PubMed ID: 1036955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on drug metabolism. IV. Effects of high dose administration of pentobarbital and phenylbutazone on the plasma biologic half lives in various species.
    Kitagawa H; Kamataki T; Yoshida S
    Chem Pharm Bull (Tokyo); 1968 Dec; 16(12):2320-3. PubMed ID: 4975994
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of the palatability of three nonsteroidal antiinflammatory top-dress formulations in horses.
    Longhofer SL; Reinemeyer CR; Radecki SV
    Vet Ther; 2008; 9(2):122-7. PubMed ID: 18597250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biotransformation of phenylbutazone (Butazolidin).
    Faigle JW; Dieterle W
    J Int Med Res; 1977; 5 Suppl 2():2-14. PubMed ID: 410685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, metabolism and excretion of phenylbutazone in cattle following intravenous, intramuscular and oral administration.
    Lees P; Ayliffe T; Maitho TE; Taylor JB
    Res Vet Sci; 1988 Jan; 44(1):57-67. PubMed ID: 3375589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Absorption and excretion of cefatrizine (S-640 P) in rabbit, dog and monkey (author's transl)].
    Matsuzaki M; Onodera K; Hirata Y; Matsumoto H; Ochiai K
    Jpn J Antibiot; 1976 Jan; 29(1):77-82. PubMed ID: 817049
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of phenylbutazone in two age groups of ponies: a preliminary study.
    Lees P; Maitho TE; Taylor JB
    Vet Rec; 1985 Mar; 116(9):229-32. PubMed ID: 4002593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of top-dress formulations of suxibuzone and phenylbutazone on development of gastric ulcers in horses.
    Andrews FM; Reinemeyer CR; Longhofer SL
    Vet Ther; 2009; 10(3):113-20. PubMed ID: 20037965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bioavailability of phenylbutazone in the horse.
    Smith PB; Caldwell J; Smith RL; Horner MW; Moss MS
    Xenobiotica; 1987 Apr; 17(4):435-43. PubMed ID: 3604253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On an iodinated derivative of 1,2-diphenyl-4-n-butyl-3,5-pyrazolidinedione].
    CONTI L
    Farmaco Prat; 1961 May; 16():240-3. PubMed ID: 13695183
    [No Abstract]   [Full Text] [Related]  

  • 17. Preparation and evaluation of electrophilic derivatives of phenylbutazone as inhibitors of prostaglandin-H synthase.
    Vennerstrom JL; Holmes TJ
    J Med Chem; 1987 Mar; 30(3):563-7. PubMed ID: 3102742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metabolism of cefatrizine (S-640P) in rat, rabbit, dog, monkey and human (author's transl)].
    Matsuzaki M; Ohtawa M; Akiyama I; Yamamato M; Tomioka J
    Jpn J Antibiot; 1976 Jan; 29(1):90-106. PubMed ID: 817050
    [No Abstract]   [Full Text] [Related]  

  • 19. A double-blind comparison of phenylbutazone and suxibuzone, a prodrug of phenylbutazone, in rheumatoid arthritis.
    Mizushima Y; Shiokawa Y; Honma M; Kageyama T
    Int J Tissue React; 1983; 5(1):35-9. PubMed ID: 6345427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promotion of hepatocarcinogenesis by suxibuzone in rats initiated with 3'-methyl-4-dimethylaminoazobenzene.
    Yanagi S; Sakamoto M; Takahashi S; Tsutsumi M; Konishi Y; Shibata K; Kamiya T
    Cancer Lett; 1987 Jul; 36(1):11-8. PubMed ID: 3107799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.